We are live on
!
Find out more
AG
Algert Global Portfolio holdings
AUM
$6.65B
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+0.68%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$751M
AUM Growth
+$454M
(+153%)
Cap. Flow
+$461M
Cap. Flow
% of AUM
61.32%
Top 10 Holdings %
Top 10 Hldgs %
5.61%
Holding
1,112
New
694
Increased
236
Reduced
72
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Graco
GGG
|
+$3.59M |
| 2 |
ScottsMiracle-Gro
SMG
|
+$3.48M |
| 3 |
Reliance Steel & Aluminium
RS
|
+$3.36M |
| 4 |
Builders FirstSource
BLDR
|
+$3.01M |
| 5 |
New York Times
NYT
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.98M |
| 2 |
Archer Daniels Midland
ADM
|
+$1.92M |
| 3 |
Domino's
DPZ
|
+$1.77M |
| 4 |
NVIDIA
NVDA
|
+$1.77M |
| 5 |
Cleveland-Cliffs
CLF
|
+$1.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Healthcare | 13.9% |
| 3 | Industrials | 13.87% |
| 4 | Consumer Discretionary | 13.47% |
| 5 | Financials | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Theravance Biopharma
TBPH
$871M
| $136K | 0.02% |
+18,380
| New | +$206K |
|
|
DZSI
952
DELISTED
DZS Inc. Common Stock
DZSI
| $136K | 0.02% |
+11,082
| New | +$174K |
|
|
BCEL
953
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $135K | 0.02% |
21,610
+3,290
| +18% | +$21.9K |
|
|
DCH
954
Dauch Corp
DCH
$1.35B
| $134K | 0.02% |
+15,234
| New | +$140K |
|
955
Puma Biotechnology
PBYI
$401M
| $130K | 0.02% |
+18,588
| New | +$139K |
|
956
Seres Therapeutics
MCRB
$51.1M
| $124K | 0.02% |
+893
| New | +$175K |
|
957
Clear Channel Outdoor Holdings
CCO
$1.23B
| $123K | 0.02% |
+45,404
| New | +$113K |
|
958
Bionano Genomics
BNGO
$12.9M
| $114K | 0.02% |
35
-23
| -40% | -$80.4K |
|
959
Kodak
KODK
$813M
| $111K | 0.01% |
+16,335
| New | +$119K |
|
960
Dianthus Therapeutics
DNTH
$5.62B
| $109K | 0.01% |
939
-558
| -37% | -$65K |
|
961
FuelCell Energy
FCEL
$1.8B
| $109K | 0.01% |
+542
| New | +$108K |
|
962
XWELL
XWEL
$9.04M
| $109K | 0.01% |
3,716
-316
| -8% | -$10.2K |
|
963
Solid Biosciences
SLDB
$797M
| $108K | 0.01% |
3,012
+586
| +24% | +$24.9K |
|
964
Quad
QUAD
$441M
| $105K | 0.01% |
24,622
+7,692
| +45% | +$31.8K |
|
965
SiriusPoint
SPNT
$2.89B
| $104K | 0.01% |
+11,270
| New | +$108K |
|
966
Ocular Therapeutix
OCUL
$1.88B
| $101K | 0.01% |
+10,100
| New | +$113K |
|
967
Radiant Logistics
RLGT
$424M
| $101K | 0.01% |
15,808
+4,928
| +45% | +$31.7K |
|
968
Future Fuel
FF
$214M
| $100K | 0.01% |
+14,040
| New | +$117K |
|
|
ENDP
969
DELISTED
Endo International plc
ENDP
| $99K | 0.01% |
+30,402
| New | +$107K |
|
|
UBX
970
DELISTED
Unity Biotechnology
UBX
| $97K | 0.01% |
+3,241
| New | +$114K |
|
971
WisdomTree
WT
$3.05B
| $97K | 0.01% |
+17,067
| New | +$105K |
|
972
Conduent
CNDT
$234M
| $94K | 0.01% |
+14,190
| New | +$97.5K |
|
973
Inovio Pharmaceuticals
INO
$87.2M
| $92K | 0.01% |
+1,074
| New | +$108K |
|
974
Invesco Mortgage Capital
IVR
$804M
| $91K | 0.01% |
+2,886
| New | +$93.8K |
|
|
NPKI
975
NPK International
NPKI
$1.25B
| $88K | 0.01% |
26,766
-21,904
| -45% | -$61.9K |
|
Similar funds
TB
CI
MIP
AS
NMIMC
AACR
MSE
FLPIM
Algert Global's Q3 2021 Portfolio in Review
As of Q3 2021, Algert Global held 1,112 positions worth $751M, up 153% from $297M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
Algert Global deployed $461M of net new capital in Q3 2021, opening 694 new positions and adding to 236 existing holdings. Its largest new stake was Graco: 46,847 shares worth $3.28M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was NVIDIA, an estimated $1.77M trimmed.
- Algert Global's largest Q3 2021 buy was Graco: 46,847 shares worth $3.28M.
- Algert Global added most to ScottsMiracle-Gro in Q3 2021, an estimated $3.48M increase.
- Algert Global's biggest Q3 2021 reduction was NVIDIA, cutting an estimated $1.77M.
- Algert Global fully exited Nike in Q3 2021, selling an estimated $1.98M.
- Algert Global's ten largest holdings make up 5.6% of its $751M portfolio in Q3 2021.
- Algert Global opened 694 new positions and closed 104 in Q3 2021.
- Algert Global's portfolio value rose 153% quarter-over-quarter to $751M.
Based on Algert Global's 13F filing for Q3 2021, filed 15 Nov 2021.